Problems and Pitfalls of Identifying Remyelination in Multiple Sclerosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32386552.
- Also identified by DOI 10.1016/j.stem.2020.03.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Regenerative medicines that promote remyelination in multiple sclerosis (MS) are making the transition from laboratory to clinical trials. While animal models provide the experimental flexibility to analyze mechanisms of remyelination, here we discuss the challenges in understanding where and how remyelination occurs in MS.
Medical subject headings
- Multiple Sclerosis
- Remyelination